DAX and CAC 40 edge higher as Stellantis leads risers and Qiagen weighs on healthcare
European benchmarks closed modestly higher on Friday with breadth favouring advancers, though volume was light across the major indices and the session's largest moves were concentrated in a handful of names.
The DAX rose 0.59 per cent to 26,136.56 and the CAC 40 added 0.37 per cent to 8,484.43 on Friday, extending the one-month gains that have left both indices within striking distance of their 52-week highs. Of the 78 companies that traded across the two markets, 50 advanced and 28 declined. The Euro Stoxx 50 climbed 0.63 per cent to 6,462.22. Volume on all three benchmarks registered at zero times the 20-day average, a figure that points to thin participation rather than conviction.
- DAX close 26,136.56, +0.59 per cent, 1.6 per cent below 52-week high
- CAC 40 close 8,484.43, +0.37 per cent, 3.1 per cent below 52-week high
- Stellantis +4.21 per cent to €4.649, 55.7 per cent below 52-week high
- Qiagen -3.02 per cent to €37.565, 21.1 per cent below 52-week high
- Benchmark volume at zero times 20-day average
Risers led by Stellantis
| Instrument | Close | Day | 5-day | Volume vs avg |
|---|---|---|---|---|
| Stellantis EUR | 4.65 | +4.21% | +0.85% | 0.96x |
| Teleperformance EUR | 71.74 | +2.87% | +1.24% | 1.25x |
| Adidas EUR | 154.45 | +2.28% | -1.97% | 0.48x |
| Fresenius Medical Care EUR | 40.14 | -1.83% | -2.19% | 1.33x |
| MTU Aero Engines EUR | 352.4 | -1.92% | -7.92% | 1.14x |
| Qiagen EUR | 37.57 | -3.02% | +0.74% | 0.91x |
| Source: exchange closing data via Yahoo Finance, session of 2026-08-21. | ||||
Stellantis
Stellantis shares rose 4.21 per cent to €4.649 on volume of 0.96 times the 20-day average. The move lifts the stock from a one-month decline of 7.43 per cent, though it remains 55.7 per cent below its 52-week high of €10.494. The automotive group, which operates brands including Jeep, Peugeot, Fiat and Opel across Europe and North America, has seen its valuation compress sharply over the past year as investors weigh cyclical demand, inventory levels and the cost of the electric transition.
The session's reported news flow included analyst target cuts, a 955,000-vehicle recall and a special-edition Wrangler launch. None of these items can be identified as the driver of the price move. The recall, if it carries warranty and logistics costs, would normally pressure margins, yet the shares advanced. Volume below the 20-day average suggests the bounce was not heavily traded. For European automotive suppliers, a sustained recovery in Stellantis would ease pressure on order books, but the stock's distance from its high indicates the market still prices a difficult earnings trajectory.
Teleperformance
Teleperformance gained 2.87 per cent to €71.74 on volume of 1.25 times the 20-day average, the only one of the six highlighted names to trade above its recent norm. The business services group, which provides customer experience management and digital services to multinational clients, has risen 31.97 per cent over the past month and now sits 8.2 per cent below its 52-week high of €78.14. The five-day move of 1.24 per cent shows the uptrend persisting.
Reported news items attached to the ticker on Friday concerned other companies entirely, Bekaert's buyback, CTS Eventim's earnings, Regeneron's FDA approval and Bayer's clinical data, indicating the data feed may have misattributed headlines. With no Teleperformance-specific catalyst visible, the advance continues a month-long rerating that has added roughly €17 per share. For European outsourcing buyers, a higher Teleperformance share price raises the cost of acquisition should consolidation resume in the sector, while clients negotiating contracts may face a counterparty with stronger balance-sheet leverage.
Adidas
Adidas added 2.28 per cent to €154.45 on volume of just 0.48 times the 20-day average, the lightest turnover of the six movers. The sportswear manufacturer, which sells footwear, apparel and accessories through wholesale, direct-to-consumer and e-commerce channels globally, has fallen 12.49 per cent over the past month and trades 21.4 per cent below its 52-week high of €196.40. The five-day change of -1.97 per cent shows the downtrend intact despite Friday's bounce.
A reported item on Stitch Fix expanding categories and AI personalisation offers no direct read-across to Adidas. The low volume suggests the rise may reflect short-covering or index rebalancing flows rather than fundamental buying. For European retail and wholesale partners, Adidas's share price remains a barometer of discretionary spending power; the 21 per cent discount to the yearly high implies the market expects margin pressure from inventory clearance and promotional activity to persist through the second half.
Fallers led by Qiagen
Qiagen
Qiagen declined 3.02 per cent to €37.565 on volume of 0.91 times the 20-day average. The life sciences company, which provides sample and assay technologies for molecular diagnostics, applied testing and academic research, has gained 2.71 per cent over the past month but remains 21.1 per cent below its 52-week high of €47.595. The five-day move of +0.74 per cent shows recent resilience before Friday's drop.
The only reported headline referenced Bio-Rad's share-price momentum, not Qiagen itself. With no company-specific news, the fall may reflect sector rotation out of diagnostics after a period of pandemic-driven revenue normalisation. For European hospital and laboratory budgets, a lower Qiagen valuation reduces the cost of potential take-private or merger scenarios, though the company's recurring reagent revenue model typically supports a floor. The 21 per cent gap to the high suggests the market is still pricing a growth deceleration from the Covid peak.
MTU Aero Engines
MTU Aero Engines fell 1.92 per cent to €352.40 on volume of 1.14 times the 20-day average. The aero-engine manufacturer, which develops and produces commercial and military engine modules and provides maintenance services, has dropped 7.92 per cent over five days despite a one-month gain of 4.79 per cent. The stock sits 12.9 per cent below its 52-week high of €404.80.
No MTU-specific news appeared in the day's feed. The five-day decline of nearly 8 per cent on above-average volume points to institutional selling, possibly linked to airline order deferrals or supply-chain cost updates that have not yet been publicly disclosed. For European aerospace supply chains, MTU's share price acts as a leading indicator for aftermarket demand; a sustained move below €350 would signal expectations of slower shop-visit rates and lower spare-parts revenue in the next 12 to 18 months.
Fresenius Medical Care
Fresenius Medical Care slipped 1.83 per cent to €40.14 on volume of 1.33 times the 20-day average, the heaviest relative turnover of the session. The dialysis services and products provider, which operates clinics and sells machines and disposables worldwide, has fallen 6.63 per cent over the past month and 2.19 per cent over five days. It trades 16.1 per cent below its 52-week high of €47.86.
No company-specific headline was reported. The above-average volume on a down day suggests active redistribution rather than passive drift. For European healthcare systems that contract with Fresenius for renal replacement therapy, the share-price weakness reflects ongoing reimbursement pressure and labour-cost inflation in key markets including Germany and the United States. A further decline towards the 52-week low of €34.57 would imply the market is pricing structural margin compression rather than a cyclical trough.
Session reading: idiosyncratic moves in thin conditions
Friday's session produced no coherent sector theme. The three risers, an automotive group, a business services firm and a sportswear maker, share no obvious supply chain, customer base or macro sensitivity. The three fallers, a diagnostics company, an aero-engine manufacturer and a dialysis provider, are equally unconnected. Volume was below the 20-day average for both benchmarks and for four of the six highlighted names, indicating that the index gains were driven by a narrow set of flows rather than broad participation.
The most striking figure remains Stellantis at 55.7 per cent below its 52-week high, a discount that prices in a profound earnings reset for Europe's second-largest carmaker by volume. Until that gap narrows, the DAX's proximity to its own high, just 1.6 per cent away, rests on the performance of a shrinking number of heavyweight names. The next test comes with the August manufacturing PMI releases and any second-quarter earnings revisions from the automotive and industrial complexes that dominate the German index.
Stellantis · three-month price
Chart: TradingView. Live prices may differ from the closing figures quoted above.